share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer MALIK AAMIR

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer MALIK AAMIR

輝瑞 | 4:持股變動聲明-高管 MALIK AAMIR
美股SEC公告 ·  09/04 06:12

牛牛AI助理已提取核心訊息

On August 31, 2024, Pfizer Inc. Executive Vice President Aamir Malik completed a sale of 20,195 shares of the company's common stock. The transaction was executed at a price of $29.01 per share, resulting in a total sale value of approximately $585,857. Following the sale, Malik's direct holdings in Pfizer common stock amounted to 29,548 shares. The sale was reported as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.
On August 31, 2024, Pfizer Inc. Executive Vice President Aamir Malik completed a sale of 20,195 shares of the company's common stock. The transaction was executed at a price of $29.01 per share, resulting in a total sale value of approximately $585,857. Following the sale, Malik's direct holdings in Pfizer common stock amounted to 29,548 shares. The sale was reported as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.
2024年8月31日,輝瑞公司執行副總裁馬利克(Aamir Malik)出售了20195股該公司的普通股。交易價格爲每股29.01美元,總銷售金額約爲585,857美元。在此次銷售之後,馬利克在輝瑞普通股的直接持倉爲29548股。根據交易代碼描述,此次銷售被報告爲以交付或扣留證券的方式來支付行權價格或稅務責任。
2024年8月31日,輝瑞公司執行副總裁馬利克(Aamir Malik)出售了20195股該公司的普通股。交易價格爲每股29.01美元,總銷售金額約爲585,857美元。在此次銷售之後,馬利克在輝瑞普通股的直接持倉爲29548股。根據交易代碼描述,此次銷售被報告爲以交付或扣留證券的方式來支付行權價格或稅務責任。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。